Heghine Khachatryan: Rethinking First-Line Therapy for Iron Deficiency Anemia in Women
Heghine Khachatryan, Editor-in-Chief at Hemostasis Today, shared a post by American Society of Hematology on LinkedIn:
“Iron deficiency anemia in women – especially those with heavy menstrual bleeding – continues to be underdiagnosed and undertreated worldwide.
New evidence published in Blood Advances and highlighted by the American Society of Hematology demonstrates that single-dose intravenous iron dextran is a cost-effective first-line therapy for this population.
When evaluated across a woman’s reproductive lifetime, IV iron provides:
- superior clinical value
- improved quality-of-life outcomes
- better long-term cost-effectiveness
compared with oral iron, which is still widely used as first-line treatment.
These findings should prompt us to reconsider current treatment algorithms and move toward more patient-centered, evidence-based care for women with iron deficiency anemia.”
Quoting American Society of Hematology’s post, adding:
“Iron deficiency anemia remains underdiagnosed and undertreated in women, particularly those with heavy menstrual bleeding.
According to new research published in Blood Advances, single-dose IV iron dextran is the cost-effective first-line therapy for this population. When evaluated across a woman’s reproductive lifetime, IV iron provided superior value and quality-of-life benefits compared with oral iron, which is currently the more predominant first-line treatment for these patients.
Learn more.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 11, 2026, 10:02Hind Hanani: Understanding the Use of Antiphospholipid Syndrome Guidelines Worldwide
-
Jan 11, 2026, 09:58Exploring the Role of Antiphospholipid Antibodies in Severe Preeclampsia – RheumNow
-
Jan 11, 2026, 09:56Adrenal Involvement in Antiphospholipid Syndrome – ARP Rheumatology
-
Jan 11, 2026, 09:52Jamie Agunsday: Understanding Pregnancy-Related Deaths
-
Jan 11, 2026, 09:44AdhesioRT Test Models Endometrial Receptivity to Optimize Implantation Timing – RBMO
-
Jan 11, 2026, 09:21ACOG Announces Maternal Health Awareness Day 2026 Webinar
-
Jan 11, 2026, 06:59John Cush: Subcutaneous Anifrolumab Effective in Lupus
-
Jan 10, 2026, 06:50Owen Xian Wen Tan: New Insights on β2-Glycoprotein I in Thrombosis Regulation
-
Jan 10, 2026, 06:35John Cush: Assess Reproductive Health in SLE Clinic Visits